"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 4 | 2 | 6 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 2 | 5 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 4 | 4 |
| 2016 | 4 | 1 | 5 |
| 2017 | 5 | 1 | 6 |
| 2018 | 5 | 8 | 13 |
| 2019 | 5 | 3 | 8 |
| 2020 | 4 | 9 | 13 |
| 2021 | 2 | 6 | 8 |
| 2022 | 2 | 9 | 11 |
| 2023 | 0 | 1 | 1 |
| 2024 | 3 | 5 | 8 |
| 2025 | 6 | 3 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025 Aug 01; 5(8):1288-1297.
-
Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer. J Immunother Cancer. 2025 Jun 22; 13(6).
-
Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision-Directed Delta-Like Ligand-3 Therapies. Am Soc Clin Oncol Educ Book. 2025 Jun; 45(3):e472794.
-
Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis. Cancer Lett. 2025 Sep 01; 627:217825.
-
Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy. Clin Cancer Res. 2025 May 15; 31(10):1821-1823.
-
Immunomodulatory effects of intratumoral cowpea mosaic virus and calreticulin nanoparticles in canine tumors: early results. Front Immunol. 2025; 16:1566394.
-
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies. Int J Mol Sci. 2025 Apr 19; 26(8).
-
Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025 Apr 01; 135(7).
-
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies. Cancer Metastasis Rev. 2025 Jan 25; 44(1):27.
-
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 2024 Oct 20; 13(20).